Announced details
Wholesale and import/export of Western medicines, relief of cold symptoms, constipation medication and e-commerce sales in China
Positioned as a measure to increase utilization of the existing infrastructure. Specific quantitative effects are Not disclosed.
Wholesale sales to Tmall, JD.com and Alibaba Health. Cumulative usage figures and other details are Not disclosed.
UNIVA Hong Kong Trading Limited is a consolidated subsidiary of the company. UHKT conducts wholesale sales to Tmall, JD.com and Alibaba Health. For the two Western medicines, contracts with the respective registration certificate holders are a condition of wholesale sales.
Advance Pharmaceutical Company Limited is a manufacturer in Hong Kong. 皇漢堂製薬 is a Japanese manufacturer. Japan Pharmaceutical Trading Limited is the Hong Kong registration certificate holder for 皇漢堂便秘丸. Tmall, JD.com and Alibaba Health are major e-commerce platforms in China. The Government of the Hong Kong Special Administrative Region is the licensing authority. Other details are Not disclosed.
Application for a Western medicine wholesale license (Wholesale Dealer Licence) accepted. The registration number and expiration date are Not disclosed.
Hong Kong
The impact on consolidated results is expected to be immaterial.
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Western medicine wholesale and import/export business, 樂信感冒靈 (Advance Neosed Tablets), 皇漢堂便秘丸 (BEAULUCK A GASTRO-RESISTANT TABLETS 5MG) |
| Counterparty | Government of the Hong Kong Special Administrative Region, Advance Pharmaceutical Company Limited, Japan Pharmaceutical Trading Limited, 皇漢堂製薬, 天猫 (Tmall), 京東 (JD.com), アリババヘルス (Alibaba Health) |
| Counterparty overview | Advance Pharmaceutical Company Limited is a manufacturer in Hong Kong. 皇漢堂製薬 is a Japanese manufacturer. Japan Pharmaceutical Trading Limited is the Hong Kong registration certificate holder for 皇漢堂便秘丸. Tmall, JD.com and Alibaba Health are major e-commerce platforms in China. The Government of the Hong Kong Special Administrative Region is the licensing authority. Other details are Not disclosed. |
| Relationship with the Company | UNIVA Hong Kong Trading Limited is a consolidated subsidiary of the company. UHKT conducts wholesale sales to Tmall, JD.com and Alibaba Health. For the two Western medicines, contracts with the respective registration certificate holders are a condition of wholesale sales. |
| Launch date | The license is expected to be obtained by April 2027. The start date of the Western medicine wholesale business is Not disclosed. |
| Applicable area | Wholesale and import/export of Western medicines, relief of cold symptoms, constipation medication and e-commerce sales in China |
| Registration number and expiry date | Application for a Western medicine wholesale license (Wholesale Dealer Licence) accepted. The registration number and expiration date are Not disclosed. |
| Location | Hong Kong |
| Location scale | More than 150 products held in inventory |
| Quantitative Effects | Positioned as a measure to increase utilization of the existing infrastructure. Specific quantitative effects are Not disclosed. |
| Usage history | Wholesale sales to Tmall, JD.com and Alibaba Health. Cumulative usage figures and other details are Not disclosed. |
| Impact on Business Performance | The impact on consolidated results is expected to be immaterial. |
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The aim is to expand the scope of products handled from Chinese herbal medicines and health foods to Western medicines, thereby increasing utilization of the e-commerce sales channels, logistics, personnel and operating infrastructure already established. The company also seeks to diversify its product range, internationalize its sourcing base and spread the risks associated with market fluctuations and regulatory changes in specific categories.